1326P Osimertinib in patients with EGFR-mutated NSCLC and leptomeningeal or brain metastases: Results of the IFCT-1804 ORBITAL trial

Autor: Planchard, D., Toffart, A.C., Madroszyk Flandin, A-C., Wislez, M., Martinez, S., Monnet, I., Hiret, S., Gounant, V., Métivier, A-C., Domblides, C., Giroux-Leprieur, E., Huchot, E., Tomasini, P., Mascaux, C., Carmier, D., Langlais, A., Morin, F., Westeel, V., Cortot, A.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S765-S766
Databáze: ScienceDirect